Tamsulosin Hydrochloride Capsule
Product Images NDC 33342-159

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 33342-159). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cart (Tamsulosin Carton 0.4mg 100s)

Tamsulosin Hydrochloride Capsules, USP 0.4 mg oral capsules packaging label showing Macleods Pharma USA as the manufacturer. The label includes dosage strength, quantity of 100 capsules (10 x 10 unit dose), storage instructions, and cautionary notes. The packaging also displays a barcode and indicates it is a prescription drug.*

FDA Label Image

1000 (Tamsulosin Fig 0.4mg 1000s)

Label for Tamsulosin Hydrochloride Capsules USP, 0.4 mg strength, with quantity of 1000 capsules. The label includes dosage form and strength details, storage instructions, manufacturer information, lot and expiration date placeholders, and read-accompanying-prescribing-information advisory. Labeler is Macleods Pharmaceuticals Limited with manufacturing locations in Plainsboro, NJ, and Baddi, Himachal Pradesh, India.*

FDA Label Image

100 (Tamsulosin Fig 0.4mg 100s)

Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg, oral dosage form. The label shows Macleods Pharma USA as the labeler and manufacturer information including Macleods Pharmaceuticals Ltd., India. Package size is 100 capsules. The label includes usage instructions, storage conditions, and regulatory information including NDC 33342-159-11.*

FDA Label Image

30 (Tamsulosin Fig 0.4mg 30s)

Label for Tamsulosin Hydrochloride Capsules USP 0.4 mg by Macleods Pharmaceuticals Limited. The label shows a 30 capsule count and states the product is for oral use. Storage instructions specify 20° to 25°C, with permitted excursions. Manufacturer details include Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Lab (Tamsulosin Fig 0.4mg 500s)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, manufactured by Macleods Pharmaceuticals Limited. The label shows a 500-capsule package for oral use. It includes storage instructions, dosage note, barcodes, and manufacturer information for Macleods Pharma USA, Inc. and Macleods Pharmaceuticals Ltd., India.*

FDA Label Image

Fig (Tamsulosin Fig 1)

A line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours) comparing fasted and fed states. The fasted state is depicted by a dashed line with a higher peak around 4 hours, while the fed state is shown with a solid line with a lower peak and delayed absorption, both declining towards 36 hours.*

FDA Label Image

Fig (Tamsulosin Fig 2a)

A line graph showing mean change over duration of treatment (weeks) for Tamsulosin Hydrochloride doses 0.8 mg and 0.4 mg, compared to placebo. The x-axis represents weeks of treatment up to 13, and the y-axis shows mean change values, with distinct lines for the two doses and placebo, illustrating decreasing mean change over time with treatment.*

FDA Label Image

Fig (Tamsulosin Fig 2b)

A line graph displaying mean change over time by duration of treatment in weeks (0 to 13 weeks) comparing three groups: Tamsulosin Hydrochloride 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change, and the x-axis shows treatment duration with sample sizes noted at each time point. The graph illustrates decreasing mean change values over treatment duration for both dosage groups compared to placebo.*

FDA Label Image

Fig (Tamsulosin Fig 3a)

A line graph illustrating mean change in measuring variable (mL/sec) over a 13-week treatment duration for Tamsulosin Hydrochloride 0.4 mg, 0.8 mg, and placebo groups. The x-axis represents weeks of treatment, and the y-axis shows mean change. Data points for each treatment group are tracked over time, indicating treatment effects compared to placebo.*

FDA Label Image

Fig (Tamsulosin Fig 3b)

A line graph showing mean change in mL/sec over duration of treatment in weeks for three groups: 0.8 mg, 0.4 mg, and placebo. The y-axis represents mean change in mL/sec, ranging from 0 to 3.0, and the x-axis shows treatment duration from 0 through 13 weeks and LOCF. The graph compares treatment effects over time.*

FDA Label Image

Str (Tamsulosin Str)

Chemical structure of tamsulosin hydrochloride, showing the molecular arrangement of functional groups including methoxy, sulfonamide, and hydrochloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.